Research
Metabolic adaptation
Patients in the semaglutide group experienced greater weight loss compared to the control group (−8.2% vs. −4.6%; P <0.001).
Semaglutide may be effective for weight management in patients post-ablation.
StrongSupportsmedium confidence
During the 12-month follow-up, the semaglutide group showed greater weight loss (−8.2% [3.2] versus −4.6% [2.9]; P <0.001).
Why this rating
The study is a prospective cohort with a significant sample size.
Source
Effect of Semaglutide on Atrial Arrhythmias Recurrence Following Ablation for Atrial Fibrillation: A Prospective Study
Jiongchao Guo et al. · Circulation Arrhythmia and Electrophysiology · 2025
DOI 10.1161/circep.125.014069
cohort · n=437Cited 6×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Semaglutide treatment following catheter ablation for atrial fibrillation is associated with a lower rate of atrial arrhythmia recurrence over 12 months (hazard ratio, 0.68; P =0.030).Strong
- Semaglutide treatment led to larger reductions in glycated hemoglobin levels compared to the control group (−1.3% vs. −0.6%; P <0.001).Strong
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →